Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
BioBlast®
Biosimilars Deals 2023
Diversity
Masterclasses
Other Podcasts
Other Updates
Our Awards
Patent Case Summaries
Patent Litigation
Patents
PipCast®
PTE
Trade Marks
Webinars

Sandoz Subsidiary Lek Commences Construction of US$400M Biologics Facility

Dec 12, 2023

Sandoz subsidiary Lek announced it has commenced construction of its US$400M biopharmaceutical production centre in Lendava, Slovenia.  The facility aims to be Europe’s most efficient producer of active pharmaceutical ingredients for biologics, and will have approximately 40,000 m2 surface area.  Full operation is planned for the end of 2026.

Sandoz signed an MOU to build the facility on 9 March 2023.